Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

Microneedling mildly regrows hair in androgenetic alopecia but not in other types.

Monthly PRP therapy is more effective than daily minoxidil for alopecia areata.

EPC-K is stable except at very acidic pH or when exposed to sunlight, and it can decompose in low ethanol concentrations.

The optimal mix of Dendropanax, sea salt, and other extracts can help reduce hair loss.

The updated SALT II tool offers a more precise way to measure scalp hair loss.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

People with alopecia areata often have lower vitamin D levels than healthy people.

Minoxidil-dutasteride tattooing can potentially help regrow hair, especially in men who already have some thin hair.

Rice husk and bran extracts from the Bue Bang 3 CMU variety can potentially treat hair loss due to their antioxidant, anti-inflammatory, and anti-androgenic properties.

There are two main types of alopecia areata with different severity, and diagnosis is made through clinical examination and trichoscopy, influencing treatment choices.

Liquid nitrogen cryotherapy is an effective treatment for alopecia areata.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Microneedling with Triamcinolone acetonide is an effective, less invasive, and safe alternative to direct injections for treating alopecia areata.

Tofacitinib effectively treats Alopecia Areata.

Hair UpTM effectively and safely promotes hair regrowth, especially in minors.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Balneophototherapy effectively treats ichthyosis linearis circumflexa but may need ongoing treatment due to short remission.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

PRP therapy effectively treats alopecia areata and atrophic acne scars.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Low vitamin D can worsen pediatric alopecia areata.

Different conditions affect how hair proteins assemble, and certain mutations can change their structure.